Label: MOTION SICKNESS RELIEF- dimenhydrinate tablet
- NDC Code(s): 63868-034-12, 63868-034-24
- Packager: CHAIN DRUG MARKETING ASSOCIATION INC
- Category: HUMAN OTC DRUG LABEL
- DEA Schedule: None
Drug Label Information
Updated September 16, 2024
If you are a consumer or patient please visit this version.
- Download DRUG LABEL INFO: PDF XML
- Official Label (Printer Friendly)
- Active ingredient (in each tablet)
- Purpose
- Uses
-
Warnings
Ask a doctor before use if you have
- a breathing problem such as emphysema or chronic bronchitis
- glaucoma
- difficulty in urination due to enlargement of the prostate gland
-
Directions
- to prevent motion sickness, the first dose should be taken one-half to one hour before starting activity
adults and children 12 years and over 1 to 2 tablets every 4-6 hours; do not exceed 8 tablets in 24 hours, or as directed by a doctor children 6 to under 12 years ½ to 1 tablet every 6-8 hours; do not exceed 3 tablets in 24 hours, or as directed by a doctor children 2 to under 6 years ½ tablet every 6-8 hours; do not exceed 1½ tablets in 24 hours, or as directed by a doctor - Other information
- Inactive ingredients
- Questions?
-
Principal Display Panel
NDC 63868-034-12
QC®
QUALITY
CHOICECompare to the
Active Ingredient in
DRAMAMINE® ORIGINAL FORMULA*Motion Sickness Relief
Original Formula
Dimenhydrinate 50 mg | AntiemeticPrevents: Nausea, Vomiting & Dizziness
for Children & Adultsactual
size24 Tablets
*This product is not manufactured or distributed by
Medtech Products Inc., owner of the registered trademark
Dramamine® Original Formula.
50844 REV0518B19808TAMPER EVIDENT: DO NOT USE IF PACKAGE IS OPENED OR IF BLISTER
UNIT IS TORN, BROKEN OR SHOWS ANY SIGNS OF TAMPERING100% QC
SATISFACTION
GUARANTEEDDistributed by C.D.M.A., Inc.©
43157 W 9 Mile Rd
Novi, MI 48375
www.qualitychoice.com
Questions: 248-449-9300
Quality Choice 44-198
-
INGREDIENTS AND APPEARANCE
MOTION SICKNESS RELIEF
dimenhydrinate tabletProduct Information Product Type HUMAN OTC DRUG Item Code (Source) NDC:63868-034 Route of Administration ORAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength DIMENHYDRINATE (UNII: JB937PER5C) (DIPHENHYDRAMINE - UNII:8GTS82S83M, 8-CHLOROTHEOPHYLLINE - UNII:GE2UA340FM) DIMENHYDRINATE 50 mg Inactive Ingredients Ingredient Name Strength CROSCARMELLOSE SODIUM (UNII: M28OL1HH48) DIBASIC CALCIUM PHOSPHATE DIHYDRATE (UNII: O7TSZ97GEP) MAGNESIUM STEARATE (UNII: 70097M6I30) MICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U) SILICON DIOXIDE (UNII: ETJ7Z6XBU4) STEARIC ACID (UNII: 4ELV7Z65AP) Product Characteristics Color white Score 2 pieces Shape ROUND Size 9mm Flavor Imprint Code 44;198 Contains Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:63868-034-12 2 in 1 CARTON 12/01/1992 05/16/2026 1 6 in 1 BLISTER PACK; Type 0: Not a Combination Product 2 NDC:63868-034-24 4 in 1 CARTON 12/01/1992 05/16/2026 2 6 in 1 BLISTER PACK; Type 0: Not a Combination Product Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date OTC Monograph Drug M009 12/01/1992 05/16/2026 Labeler - CHAIN DRUG MARKETING ASSOCIATION INC (011920774) Establishment Name Address ID/FEI Business Operations LNK International, Inc. 038154464 pack(63868-034) Establishment Name Address ID/FEI Business Operations LNK International, Inc. 832867837 manufacture(63868-034) , pack(63868-034) Establishment Name Address ID/FEI Business Operations LNK International, Inc. 117025878 manufacture(63868-034)